BG108571A - Crystalline composition containing escitalopram - Google Patents

Crystalline composition containing escitalopram

Info

Publication number
BG108571A
BG108571A BG108571A BG10857104A BG108571A BG 108571 A BG108571 A BG 108571A BG 108571 A BG108571 A BG 108571A BG 10857104 A BG10857104 A BG 10857104A BG 108571 A BG108571 A BG 108571A
Authority
BG
Bulgaria
Prior art keywords
composition containing
crystalline composition
containing escitalopram
escitalopram
crystalline particles
Prior art date
Application number
BG108571A
Other languages
Bulgarian (bg)
English (en)
Inventor
Troels Christensen
Ken Liljegren
Michiel Elema
Lene Andresen
Shashank Mahashabde
Sebastian Assenza
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG108571(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG108571A publication Critical patent/BG108571A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
BG108571A 2001-07-31 2004-02-09 Crystalline composition containing escitalopram BG108571A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101164 2001-07-31

Publications (1)

Publication Number Publication Date
BG108571A true BG108571A (en) 2005-02-28

Family

ID=8160647

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108571A BG108571A (en) 2001-07-31 2004-02-09 Crystalline composition containing escitalopram

Country Status (39)

Country Link
US (3) US6916941B2 (de)
EP (2) EP1414435B1 (de)
JP (4) JP2005525993A (de)
KR (1) KR20040028947A (de)
CN (2) CN1311819C (de)
AR (1) AR034898A1 (de)
AT (2) ATE352546T1 (de)
AU (1) AU2002355624B2 (de)
BG (1) BG108571A (de)
BR (1) BR0206164A (de)
CA (1) CA2451915C (de)
CO (1) CO5560540A2 (de)
CY (1) CY1106413T1 (de)
DE (2) DE60217932T2 (de)
DK (2) DK1414435T3 (de)
EA (1) EA006213B1 (de)
EG (1) EG24206A (de)
ES (2) ES2280892T3 (de)
HR (2) HRP20031073A2 (de)
HU (1) HUP0401946A2 (de)
IL (2) IL159326A0 (de)
IS (1) IS7077A (de)
MA (1) MA27349A1 (de)
ME (1) MEP2108A (de)
MX (1) MXPA04000849A (de)
MY (1) MY126238A (de)
NO (1) NO328346B1 (de)
NZ (1) NZ530157A (de)
PE (1) PE20030304A1 (de)
PL (1) PL366995A1 (de)
PT (2) PT1414435E (de)
RS (1) RS8304A (de)
SI (1) SI1414435T1 (de)
TN (1) TNSN04021A1 (de)
TR (1) TR200400189T2 (de)
UA (1) UA79930C2 (de)
UY (1) UY27404A1 (de)
WO (1) WO2003011278A1 (de)
ZA (1) ZA200309684B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145615A0 (en) 1999-04-14 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram
AR040970A1 (es) 2002-08-12 2005-04-27 Lundbeck & Co As H Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
US20110196032A1 (en) * 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR20070067173A (ko) * 2005-08-29 2007-06-27 테바 파마슈티컬 인더스트리즈 리미티드 이정점 입도 분포를 갖는 고체 미립자 타달라필
KR20080080094A (ko) 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
US8252336B2 (en) 2006-10-20 2012-08-28 Ratiopharm Gmbh Escitalopram and solid pharmaceutical composition comprising the same
US20090048336A1 (en) * 2007-08-17 2009-02-19 Naveen Kumar Kolla Escitalopram oxalate powders
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (de) 2008-05-07 2009-11-11 Hexal Ag Granulat mit Escitalopramoxalat
GR20080100696A (el) 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) * 2012-01-30 2013-07-31 Carthesia Sas Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
WO2017020841A1 (zh) * 2015-08-03 2017-02-09 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
WO2018190294A1 (ja) * 2017-04-10 2018-10-18 東和薬品株式会社 エスシタロプラム医薬組成物
CN107441052A (zh) * 2017-06-21 2017-12-08 山东京卫制药有限公司 一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) * 2017-11-01 2020-03-16 한국화학연구원 에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja) * 2020-06-22 2024-03-21 東和薬品株式会社 エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143703A (de) 1965-03-18
GB1358915A (en) 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
EP0223403B1 (de) 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB9325644D0 (en) 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5683720A (en) 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
EP0714663A3 (de) 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
AU5966196A (en) 1995-06-08 1997-01-09 Eli Lilly And Company Methods of treating cold and allergic rhinitis
JP3526581B2 (ja) 1997-07-08 2004-05-17 ハー・ルンドベック・アクティーゼルスカブ シタロプラムの製造方法
GB9714841D0 (en) 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
US5980941A (en) 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5840334A (en) 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
CN1286687A (zh) * 1997-11-11 2001-03-07 H·隆德贝克有限公司 制备西酞普兰的方法
WO2000023431A1 (en) 1998-10-20 2000-04-27 H. Lundbeck A/S Method for the preparation of citalopram
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
IL145615A0 (en) 1999-04-14 2002-06-30 Lundbeck & Co As H Method for the preparation of citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
WO2001022941A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
ATE352546T1 (de) * 2001-07-31 2007-02-15 Lundbeck & Co As H Kristalline zusammensetzung enthaltend escitalopram

Also Published As

Publication number Publication date
NZ530157A (en) 2007-06-29
SI1414435T1 (en) 2005-06-30
MY126238A (en) 2006-09-29
EA006213B1 (ru) 2005-10-27
US7420069B2 (en) 2008-09-02
DE60217932T2 (de) 2007-08-30
JP2012211186A (ja) 2012-11-01
CO5560540A2 (es) 2005-09-30
HRPK20080410B3 (en) 2009-09-30
CY1106413T1 (el) 2011-10-12
CA2451915C (en) 2010-09-21
DK1522539T3 (da) 2007-05-07
BR0206164A (pt) 2003-10-28
EP1522539B1 (de) 2007-01-24
PT1522539E (pt) 2007-03-30
JP5719811B2 (ja) 2015-05-20
ES2280892T3 (es) 2007-09-16
ATE352546T1 (de) 2007-02-15
MEP2108A (xx) 2010-02-10
HUP0401946A2 (hu) 2005-01-28
PL366995A1 (en) 2005-02-07
EP1414435A1 (de) 2004-05-06
TR200400189T2 (tr) 2004-12-21
EP1522539A1 (de) 2005-04-13
ZA200309684B (en) 2004-12-22
CN1660074A (zh) 2005-08-31
IS7077A (is) 2003-12-15
ATE286730T1 (de) 2005-01-15
NO328346B1 (no) 2010-02-01
MA27349A1 (fr) 2005-06-01
DK1414435T3 (da) 2005-05-09
US20030212128A1 (en) 2003-11-13
UY27404A1 (es) 2003-02-28
EA200400243A1 (ru) 2004-06-24
CN1311819C (zh) 2007-04-25
DE60202615D1 (de) 2005-02-17
HRP20080410A2 (en) 2008-10-31
HK1070000A1 (en) 2005-06-10
US20080305164A1 (en) 2008-12-11
EP1414435B1 (de) 2005-01-12
JP2005525993A (ja) 2005-09-02
IL159326A0 (en) 2004-06-01
JP5192568B2 (ja) 2013-05-08
CA2451915A1 (en) 2003-02-13
NO20040380L (no) 2004-01-28
ES2233842T3 (es) 2005-06-16
MXPA04000849A (es) 2004-05-14
PT1414435E (pt) 2005-05-31
JP2011195591A (ja) 2011-10-06
TNSN04021A1 (en) 2006-06-01
US6916941B2 (en) 2005-07-12
JP4971477B2 (ja) 2012-07-11
CN1536997A (zh) 2004-10-13
HRP20031073A2 (en) 2004-04-30
AR034898A1 (es) 2004-03-24
AU2002355624B2 (en) 2006-02-02
WO2003011278A1 (en) 2003-02-13
EG24206A (en) 2008-10-21
KR20040028947A (ko) 2004-04-03
DE60202615T2 (de) 2006-01-12
JP2010150283A (ja) 2010-07-08
US20050147674A1 (en) 2005-07-07
UA79930C2 (en) 2007-08-10
DE60217932D1 (de) 2007-03-15
PE20030304A1 (es) 2003-03-27
RS8304A (sr) 2006-12-15
IL159326A (en) 2010-05-31

Similar Documents

Publication Publication Date Title
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
AU675036B2 (en) Process for the preparation of organophilic metal oxide particles
MY121397A (en) Ziprasidone formulations
HUP9801615A2 (hu) Szimetikon/vízmentes kalcium-foszfát-kompozíciók
AU4175296A (en) Composite material containing aerogel, process for manufacturing said material and the use thereof
CA2487054A1 (en) Nanoparticulate fibrate formulations
HUP0002212A3 (en) Composition comprising finely divided, crystalline particles of budesonide and preparation thereof
CA2253797A1 (en) Luminous or fluorescent artificial stone composition
AU1289199A (en) Articles or compositions comprising nanoscale particles; methods of utilizing orproducing such particles
CA2430318A1 (en) Powder formulation and method for producing the same
CA2390338A1 (en) Binder compositions for bonding particulate material
AU2001278538A1 (en) Method for encapsulating fine solid particles in the form of microcapsules
AU2002363415A1 (en) Tightly agglomerated non-oxide particles and method for producing the same
ZA952771B (en) Novel compound
DE69907119D1 (de) Pulverisierte-Sorbitol und ihr Verfahren zur Herstellung
AP2000001837A0 (en) Pharmaceutical compositions containing micronized bicyclic drugs.
CA2307294A1 (en) Anti-caking anti-mycotic food ingredient and process for producing the same
AU2002219180A1 (en) Clay composition
IT1269508B (it) Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle
AU2002246211A1 (en) Solid composition containing at least 75 % by weight of solid particles and at least one non-volatile liquid oil
MY125453A (en) Silica filler and method for its production
AU2002246212A1 (en) Solid composition containing colouring material and at least 75 % by weight of solid particles
AU641411B2 (en) Nitrofurantoin crystals
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
BR9714559A (pt) Composição refratária fundìvel e métodos de fabricação de corpos refratários